Evaluation of Efficacy of Long-term Growth Hormone Therapy in Patients with Hypochondroplasia

Hypochondroplasia is a cause of disproportionate short stature and characterized by minor clinical manifestations. The aim of this study was to evaluate the efficacy of long-term growth hormone (GH) therapy in hypochondroplastic cases with inadequate response to GH stimulation tests. In this study, six patients who had a height standard deviation score of -3.43 before the treatment and a mean age of 7.42 years and who had received GH treatment at a dose of 0.2 mg/kg/week for a mean period of 4.45 years were evaluated. A good response was found in the first year of treatment, but this increase was not found to be sufficient for the patients to achieve an adequate final height.

Kaynakça

Meyer MF, Menken KU, Zimny S, Hellmich B, Schatz H. Pitfall in diagnosing growth hormone deficiency in a hypochondroplastic patient with a delayed puberty. Exp Clin Endocrinol Diabetes 2003;111:177- 181.

Glasgow JF, Nevin NC, Thomas PS. Hypochondroplasia. Arch Dis Child 1978;53:868-872.

Maroteaux P, Falzon P. Hypochondroplasie. Review of 80 cases. Arch Fr Pediatr 1988;45:105-109.

Rimoin DL, Cohn D, Krakow D, Wilcox W, Lachman RS, Alanay Y. The skeletal dysplasias: clinical-molecular correlations. Ann. N Y Acad Sci 2007;1117:302-309.

Hagenäs L, Hertel T. Skeletal Dysplasia, Growth Hormone Treatment and Body Proportion: Comparison with Other Syndromic and NonSyndromic Short Children. Horm Res 2003;60:65-70.

Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of The Hand and Wrist. 2nd ed. Stanford, CA: Stanford University Press, 1959.

Marshall WA, Tanner JM. Variation in the pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.

Marshall WA, Tanner JM. Variation in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.

Massart F, Miccoli M, Baggiani A, Bertelloni S. Hight outcome of short children with hypochondroplasia after recombinant human growth hormone treatment: a meta-analysis. Pharmacogenomics 2015;16:1965-1973. Epub 2015 Nov 10

Bellus GA, McIntosh I, Smith EA, Aylsworh AS, Kaitila I, Horton WA, Greenhaw GA, Hecht JT, Francomano CA. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet 1995;10:357-359.

Grigelioniene G, Eklöf O, Laurencikas E, Ollars B, Hertel NT, Dumanski JP, Hägenas L. Asn540Lys mutation in fibroblast growth factor 3 and phenotype in hypochondroplasia. Acta Paediatr 2000;89:1072-1076.

Rousseau F, Bonaventure J, Legeai-Mallet L, Schmidt H, Weissenbach J, Maroteaux P, Munnich A, Le Merrer M. Clinical and genetic heterogeneity of hypochondroplasia. J Med Genet 1996;33:749-752.

Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet 2007;370:162- 172.

Appan S, Laurent S, Chapman M, Hindmarsh PC, Brook CG. Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr Scand 1990;79:796-803.

Ramaswami U, Hindmarsh PC, Brook CG. Growth hormone therapy in hypochondroplasia. Acta Paediatr Suppl 1999;88:116-117.

Pinto G, Cormier-Daire V, Le Merrer M, Samara-Boustani D, Baujat G, Fresneau L, Viaud M, Souberbielle JC, Pineau JC, Polak M. Efficacy and safety of growth hormone treatment in children with hypochondroplasia: comparison with an historical cohort. Horm Res Paediatr 2014;82:355-363. Epub 2014 Oct 15

Kanaka-Gantenbein C. Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton). J Pediatr Endocrinol Metab 2001;14:17-26.

Kaynak Göster

590 349

Arşiv
Sayıdaki Diğer Makaleler

The Role of Irisin, Insulin and Leptin in Maternal and Fetal Interaction

Deniz OKDEMİR, NİHAL HATİPOĞLU, Selim KURTOĞLU, Ülkü Gül ŞİRAZ, Himmet Haluk AKAR, Sabahattin MUHTAROĞLU, Mehmet Serdar KÜTÜK

Insulin Resistance as Related to Psychiatric Disorders in Obese Children

Deniz Özalp KIZILAY, Şermin YALIN SAPMAZ, Semra ŞEN, Yekta ÖZKAN, BETÜL ERSOY

SLC34A3 Intronic Deletion in an Iranian Kindred with Hereditary Hypophosphatemic Rickets with Hypercalciuria

Shirin HASANİ-RANJBAR, Hanieh-Sadat EJTAHED, Mahsa M. AMOLİ, Fatemeh BİTARAFAN, Mostafa QORBANİ, Akbar SOLTANİ, Bahareh YARJOO, Hanieh-Sadat EJTAHED

Aromatase Deficiency due to a Novel Mutation in CYP19A1 Gene

Edip ÜNAL, Ruken YILDIRIM, Funda Feryal TAŞ, Vasfiye DEMİR, HÜSEYİN ONAY, YUSUF KENAN HASPOLAT

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections on Type 1 Diabetes Children: A MetaAnalysis of Randomized Control Trials

Yuan QİN, Lu-Hong YANG, Xiao-Li HUANG, Xiao-Hong CHEN, Hui YAO

Under-recognized Hypoparathyroidism in Thalassemia

Hataitip TANGNGAM, Pat MAHACHOKLERTWATTANA, Preamrudee POOMTHAVORN, Ampaiwan CHUANSUMRIT, Nongnuch SIRACHAİNAN, La-or CHAİLURKİT, Patcharin KHLAİRİT

Incidence of Type 1 Diabetes in Children Aged Below 18 Years during 2013-2015 in Northwest Turkey

ŞÜKRAN POYRAZOĞLU, RÜVEYDE BUNDAK, Zehra Yavaş ABALI, HASAN ÖNAL, Sevil SARIKAYA, ABDURRAHMAN AKGÜN, Serpil BAŞ, Saygın ABALI, ABDULLAH BEREKET, ERDAL EREN, Ömer TARIM, AYLA GÜVEN, Metin YILDIZ, Derya KARAMAN AKSAKAL, Ayşegül YÜKSEL, Gülcan SEYMEN KARABULUT, ŞÜKRÜ HATUN, Tolga ÖZGEN, Yaşar CESUR, MEHMET AZİZOĞLU, Emine

Evaluation of Efficacy of Long-term Growth Hormone Therapy in Patients with Hypochondroplasia

Tuğba ÇETİN, Zeynep ŞIKLAR, Pınar KOCAAY, Merih BERBEROĞLU

Acquired Chiari I Malformation Secondary to Spontaneous Intracranial Hypotension Syndrome and Persistent Hypoglycemia: A Case Report

HASAN ÖNAL, Atilla ERSEN, Hakan GEMİCİ, Erdal ADAL, SERHAT GÜLER, Serdar SANDER, Sait ALBAYRAM

ROHHAD Syndrome, a Rare Cause of Hypothalamic Obesity: Report of Two Cases

Ülkü Gül ŞİRAZ, Deniz OKDEMİR, Gül DİREK, Leyla AKIN, NİHAL HATİPOĞLU, MUSTAFA KENDİRCİ